- Home
- BNR vs XOS Comparison
BNR vs XOS Comparison
Compare BNR & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- XOS
- Stock Information
- Founded
- BNR 2014
- XOS 2016
- Country
- BNR China
- XOS United States
- Employees
- BNR N/A
- XOS N/A
- Industry
- BNR Medical Specialities
- XOS Construction/Ag Equipment/Trucks
- Sector
- BNR Health Care
- XOS Consumer Discretionary
- Exchange
- BNR Nasdaq
- XOS Nasdaq
- Market Cap
- BNR 38.3M
- XOS 25.6M
- IPO Year
- BNR 2020
- XOS N/A
- Fundamental
- Price
- BNR $6.36
- XOS $3.13
- Analyst Decision
- BNR
- XOS Buy
- Analyst Count
- BNR 0
- XOS 5
- Target Price
- BNR N/A
- XOS $8.80
- AVG Volume (30 Days)
- BNR 53.5K
- XOS 28.1K
- Earning Date
- BNR 08-21-2025
- XOS 08-13-2025
- Dividend Yield
- BNR N/A
- XOS N/A
- EPS Growth
- BNR N/A
- XOS N/A
- EPS
- BNR N/A
- XOS N/A
- Revenue
- BNR $72,112,038.00
- XOS $48,678,000.00
- Revenue This Year
- BNR $136.32
- XOS $1.45
- Revenue Next Year
- BNR N/A
- XOS $27.16
- P/E Ratio
- BNR N/A
- XOS N/A
- Revenue Growth
- BNR 0.53
- XOS N/A
- 52 Week Low
- BNR $2.18
- XOS $2.73
- 52 Week High
- BNR $9.48
- XOS $9.15
- Technical
- Relative Strength Index (RSI)
- BNR 56.55
- XOS 37.78
- Support Level
- BNR $6.71
- XOS $3.20
- Resistance Level
- BNR $9.48
- XOS $3.60
- Average True Range (ATR)
- BNR 0.85
- XOS 0.21
- MACD
- BNR 0.17
- XOS -0.03
- Stochastic Oscillator
- BNR 34.46
- XOS 3.33
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About XOS Xos Inc.
Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Classes 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.